86 Publications (Page 2 of 4)
2008
A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
Robertson, Michael J⋅Kirkwood, John M⋅Logan, Theodore F⋅Koch, Kevin M⋅Kathman, Steven⋅Kirby, Lyndon C⋅Bell, William N⋅Thurmond, Linda M⋅Weisenbach, Jill and Dar, Mohammed M
Clinical Cancer Research, vol. 14, (no. 11), pp. 3462-3469, 2008. | Journal Article
2007
Evaluation of the Immunological Effects of Cytokines Administered to Patients With Cancer
Robertson, Michael J
Methods in Pharmacology and Toxicology, pp. 297-317, 2007. | Journal Article
 
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
Robertson, Michael J⋅Kahl, Brad S⋅Vose, Julie M⋅de Vos, Sven⋅Laughlin, Mary⋅Flynn, Patrick J⋅Rowland, Kendrith⋅Cruz, Jose C⋅Goldberg, Stuart L⋅Musib, Luna⋅Darstein, Christelle⋅Enas, Nathan⋅Kutok, Jeffery L⋅Aster, Jon C⋅Neuberg, Donna S⋅Savage, Kerry J⋅La Casce, Ann S⋅Thornton, Donald⋅Slapak, Christopher A and Shipp, Margaret A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 25, (no. 13), pp. 1741-6, 2007/May/1. | Journal Article
2006
Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
Robertson, Michael J⋅Mier, James W⋅Logan, Theodore F⋅Atkins, Michael B⋅Koon, Henry B⋅Koch, Kevin M⋅Kathman, Steven⋅Pandite, Lini N⋅Oei, Coreen⋅Kirby, Lyndon C⋅Jewell, Roxanne C⋅Bell, William N⋅Thurmond, Linda M⋅Weisenbach, Jill⋅Roberts, Suzanne and Dar, Mohammed M
Clinical Cancer Research, vol. 12, (no. 14), pp. 4265-4273, 2006. | Journal Article
 
Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity.
Logan, Theodore F and Robertson, Michael J
Current oncology reports, vol. 8, (no. 2), pp. 114-9, 2006/Mar. | Journal Article
 
Macrophage activation syndrome and other systemic inflammatory conditions after BMT
Sreedharan, A.⋅Bowyer, S.⋅Wallace, C. A⋅Robertson, Michael J⋅Schmidt, K.⋅Woolfrey, A. E and Nelson, Robert P
Bone Marrow Transplantation, vol. 37, (no. 7), pp. 629-34, Apr 2006. | Journal Article
 
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
Fisher, Richard I⋅Bernstein, Steven H⋅Kahl, Brad S⋅Djulbegovic, Benjamin⋅Robertson, Michael J⋅de Vos, Sven⋅Epner, Elliot⋅Krishnan, Amrita⋅Leonard, John P⋅Lonial, Sagar⋅Stadtmauer, Edward A⋅O'connor, Owen A⋅Shi, Hongliang⋅Boral, Anthony L and Goy, André
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 24, (no. 30), pp. 4867-74, 2006/Oct/20. | Journal Article
 
Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
Ganjoo, Kristen⋅An, Caroline S⋅Robertson, Michael J⋅Gordon, Leo I⋅Sen, Joy A⋅Weisenbach, Jill⋅Li, Shuli⋅Weller, Edie A⋅Orazi, Attilio and Horning, Sandra J
Leukemia & lymphoma, vol. 47, (no. 6), pp. 998-1005, 2006/Jun. | Journal Article
 
The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.
Starnes, Trevor⋅Starnes, T.⋅Rasila, Kanwaldeep K⋅Rasila, K.K.⋅Robertson, Michael J⋅Robertson, M.J.⋅Brahmi, Zacharie⋅Brahmi, Z.⋅Dahl, Richard⋅Dahl, R.⋅Christopherson, Kent⋅Christopherson, K.⋅Hromas, Robert and Hromas, R.
Experimental hematology, vol. 34, (no. 8), pp. 1101-5, 2006/Aug. | Journal Article
2005
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study.
Ganjoo, Kristen⋅Ganjoo, Kristen N⋅Robertson, Michael J⋅Robertson, Michael J⋅Fisher, William⋅Fisher, William⋅Jung, Sin Ho⋅Jung, Sin-Ho⋅McClean, John⋅McClean, John⋅Huh, Sang Yoon⋅Huh, Sang Y⋅Bufill, Jose⋅Bufill, Jose⋅Williams, Sheron⋅Williams, Sheron⋅Cripe, Larry D and Cripe, Larry D
American journal of clinical oncology, vol. 28, (no. 2), pp. 169-72, 2005/Apr. | Journal Article
 
Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Robertson, Michael J⋅Abonour, Rafat⋅Hromas, Robert A⋅Nelson, Robert P⋅Fineberg, Naomi S and Cornetta, Kenneth G
Leukemia & lymphoma. , vol. 46, (no. 10), pp. 1477-87, 2005/Oct. | Journal Article
 
Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma.
Robertson, Michael J⋅Chang, Hua-Chen⋅Pelloso, David and Kaplan, Mark H
Blood. , vol. 106, (no. 3), pp. 963-70, 2005/Aug/1. | Journal Article
 
Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression
Robertson, Michael J⋅Schacterle, RS⋅Mackin, GA⋅Wilson, SN⋅Bloomingdale, KL⋅Ritz, Jerome and Komaroff, Anthony L
Clinical and Experimental Immunology, vol. 141, (no. 2), pp. 326-332, 2005. | Journal Article
2004
Immunological consequences of interleukin 12 administration after autologous stem cell transplantation.
Pelloso, David⋅Cyran, Katherine⋅Timmons, Lynette⋅Williams, Brian T and Robertson, Michael J
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 10, (no. 6), pp. 1935-42, 2004/Mar/15. | Journal Article
 
Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin's Lymphoma and Hodgkin's Disease
Younes, Anas⋅Younes, Anas⋅Younes, Anas⋅Younes, Anas⋅Younes, Anas⋅Pro, Barbara⋅Pro, Barbara⋅Pro, Barbara⋅Pro, Barbara⋅Pro, Barbara⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Flinn, Ian W⋅Flinn, Ian W⋅Flinn, Ian W⋅Flinn, Ian W⋅Flinn, Ian W⋅Romaguera, Jorge E⋅Romaguera, Jorge E⋅Romaguera, Jorge E⋅Romaguera, Jorge E⋅Romaguera, Jorge E⋅Hagemeister, Fredrick⋅Hagemeister, Fredrick⋅Hagemeister, Fredrick⋅Hagemeister, Fredrick⋅Hagemeister, Fredrick⋅Dang, Nam Hoang⋅Dang, Nam H⋅Dang, Nam H⋅Dang, Nam H⋅Dang, Nam H⋅Fiumara, Paolo⋅Fiumara, Paolo⋅Fiumara, Paolo⋅Fiumara, Paolo⋅Fiumara, Paolo⋅Loyer, Evelyne M⋅Loyer, Evelyne M⋅Loyer, Evelyne M⋅Loyer, Evelyne M⋅Loyer, Evelyne M⋅Cabanillas, Fernando F⋅Cabanillas, Fernando F⋅Cabanillas, Fernando F⋅Cabanillas, Fernando F⋅Cabanillas, Fernando F⋅McLaughlin, Peter W⋅McLaughlin, Peter W⋅McLaughlin, Peter W⋅Mc Laughlin, Peter⋅McLaughlin, Peter W⋅Rodriguez, Maria Alma⋅Rodriguez, Maria Alma⋅Rodriguez, Maria Alma⋅Rodriguez, Maria Alma⋅Rodriguez, Maria A⋅Samaniego, Felipe⋅Samaniego, Felipe⋅Samaniego, Felipe⋅Samaniego, Felipe and Samaniego, Felipe
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 10, (no. 16), pp. 5438, 2004-Aug-15. | Journal Article
2002
Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis.
Starnes, Trevor⋅Broxmeyer, Hal E⋅Robertson, Michael J and Hromas, Robert
Journal of immunology (Baltimore, Md. : 1950), vol. 169, (no. 2), pp. 642-6, 2002/Jul/15. | Journal Article
 
IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis
Starnes, T.⋅Broxmeyer, Hal E⋅Robertson, Michael J and Hromas, R.
Journal of Immunology, vol. 169, (no. 2), pp. 642-646, 2002. | Journal Article
 
Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies.
Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael J⋅Pelloso, David⋅Pelloso, David⋅Pelloso, David⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Hromas, Robert A⋅Hromas, Robert⋅Hromas, Robert⋅Nelson, Robert⋅Nelson, Robert P⋅Nelson, Robert⋅Wood, Lisa⋅Wood, Lisa⋅Wood, Lisa⋅Cornetta, Kenneth⋅Cornetta, Kenneth and Cornetta, Kenneth
Clinical Cancer Research, vol. 8, (no. 11), pp. 3383-93, 2002/Nov. | Journal Article
 
Role of chemokines in the biology of natural killer cells
Robertson, Michael J
Journal of Leukocyte Biology, vol. 71, (no. 2), pp. 173-183, 2002. | Journal Article
2001
Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?
Robertson, Michael J
The Journal of clinical investigation. , vol. 108, (no. 6), pp. 801-2, 2001/Sep. | Journal Article
 
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production.
Starnes, Trevor⋅Starnes, Trevor⋅Starnes, T⋅Robertson, Michael⋅Robertson, Michael J⋅Robertson, Michael⋅Sledge, George⋅Sledge, G⋅Sledge, George⋅Kelich, Stephanie⋅Kelich, S⋅Kelich, Stephanie⋅Nakshatri, Harikrishna⋅Nakshatri, H⋅Nakshatri, Harikrishna⋅Broxmeyer, H E⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Hromas, Robert⋅Hromas, Robert and Hromas, Robert A
Journal of immunology (Baltimore, Md. : 1950), vol. 167, (no. 8), pp. 4137-40, 2001/Oct/15. | Journal Article
 
IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production
Starnes, T.⋅Robertson, Michael J⋅Sledge, G.⋅Kelich, S.⋅Nakshatri, H.⋅Broxmeyer, HE and Hromas, Robert A
Journal of Immunology, vol. 167, (no. 8), pp. 4137-4140, 2001. | Journal Article
2000
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.
Abonour, Rafat⋅Williams, David A⋅Einhorn, Lawrence H⋅Hall, K M⋅Chen, J⋅Coffman, J⋅Traycoff, C M⋅Bank, Arthur⋅Kato, I⋅Ward, M⋅Williams, Stephen D⋅Hromas, Robert A⋅Robertson, Michael J⋅Smith, Franklin O⋅Woo, Daniel⋅Mills, B⋅Srour, Edward F and Cornetta, Kenneth G
Nature Medicine, vol. 6, (no. 6), pp. 652-8, 2000/Jun. | Journal Article
 
Regulation of Human Natural Killer Cell Migration and Proliferation by the Exodus Subfamily of CC Chemokines
Robertson, Michael J⋅Williams, BT⋅Christopherson, Kent W⋅Brahmi, Z. and Hromas, Robert A
Cellular Immunology, vol. 199, (no. 1), pp. 8-14, 2000. | Journal Article
1999
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
Borrego, F.⋅Robertson, Michael J⋅Ritz, Jerome⋅Pena, J. and Solana, R.
Immunology, vol. 97, (no. 1), pp. 159-165, 1999. | Journal Article